Abstract:In recent years, multidrug-resistant pathogenic microorganisms (MDROs) have emerged as a severe threat to human health, exhibiting robust resistance to traditional antibiotics. This has created a formidable challenge in modern medicine as we grapple with limited options to combat these resilient bacteria. Despite extensive efforts by scientists to develop new antibiotics targeting these pathogens, the quest for novel antibacterial molecules has become increasingly arduous. Fortunately, nature offers a potential solution in the form of cationic antimicrobial peptides (AMPs) and their synthetic counterparts. AMPs, naturally occurring peptides, have displayed promising efficacy in fighting bacterial infections by disrupting bacterial cell membranes, hindering their survival and reproduction. These peptides, along with their synthetic mimics, present an exciting alternative in combating antibiotic resistance. They hold the potential to emerge as a formidable tool against MDROs, offering hope for improved strategies to protect communities. Extensive research has explored the diversity, history, and structure-properties relationship of AMPs, investigating their amphiphilic nature for membrane disruption and mechanisms of action. However, despite their therapeutic promise, AMPs face several documented limitations. Among these challenges, poor pharmacokinetic properties stand out, impeding the attainment of therapeutic levels in the body. Additionally, some AMPs exhibit toxicity and susceptibility to protease cleavage, leading to a short half-life and reduced efficacy in animal models. These limitations pose obstacles in developing effective treatments based on AMPs. Furthermore, the high manufacturing costs associated with AMPs could significantly hinder their widespread use. In this review, we aim to present experimental and theoretical insights into different AMPs, focusing specifically on antibacterial peptides (ABPs). Our goal is to offer a concise overview of peptide-based drug candidates, drawing from a wide array of literature and peer-reviewed studies. We also explore recent advancements in AMP development and discuss the challenges researchers face in moving these molecules towards clinical trials. Our main objective is to offer a comprehensive overview of current AMP and ABP research to guide the development of more precise and effective therapies for bacterial infections.

Macrocyclic peptides: up-and-coming weapons to combat antimicrobial resistance

Natural and Man-Made Cyclic Peptide-Based Antibiotics

Design and synthesis of broad-spectrum antimicrobial amphiphilic peptidomimetics to combat drug-resistance

Macrocyclic peptides thwart Gram-negative bacteria

Mechanisms of Action, Biological Characteristics, and Future Prospects: A Review of Antimicrobial Peptides (A Review)

Antimicrobial peptides for combating drug-resistant bacterial infections

Antimicrobial Peptides and Cell-Penetrating Peptides: Non-Antibiotic Membrane-Targeting Strategies Against Bacterial Infections

Challenges in the development of next-generation antibiotics: opportunities of small molecules mimicking mode of action of host-defense peptides

Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance

Antimicrobial Peptides: From Design to Clinical Application

Current synthetic chemistry towards cyclic antimicrobial peptides

Advancements in peptide-based antimicrobials: A possible option for emerging drug-resistant infections

Chemically modified and conjugated antimicrobial peptides against superbugs.

Small Molecular Mimetics of Antimicrobial Peptides As a Promising Therapy to Combat Bacterial Resistance.

Antimicrobial Peptides: A Promising Solution to the Rising Threat of Antibiotic Resistance

Macrocyclic Peptides as Drug Candidates: Recent Progress and Remaining Challenges

Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens

Recent Advances in Amphipathic Peptidomimetics as Antimicrobial Agents to Combat Drug Resistance

Combating Antimicrobial Resistance by Employing Antimicrobial Peptides: Immunomodulators and Therapeutic Agents against Infectious Diseases

Antimicrobial peptide-based strategies to overcome antimicrobial resistance

Antimicrobial peptides: mechanism of action, activity and clinical potential